Author:
Ito Yoshikazu,Ohyashiki Kazuma,Hirai Hisamaru,Ogawa Seishi,Mitani Kinuko,Hotta Tomomitsu,Bessho Masami,Naoe Tomoki,Mizoguchi Hideaki,Uchiyama Takashi,Omine Mitsuhiro
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Alessandrino EP, Amadori S, Barosi G, et al. Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes: a statement from the Italian Society of Hematology. Haematologica. 2002;87:1286-1306.
2. Bowen D, Culligan D, Jowitt S, et al. Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes. Br J Haematol. 2003;120:187-200.
3. Greenberg PL, Bennett JM, Bloomfield CD, et al. Myelodysplastic syndromes: clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2003;1:456-471.
4. Raza A, Meyer P, Dutt D, et al. Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes. Blood. 2001;98:958-965.
5. List A, Beran M, DiPersio J, et al. Opportunities for Trisenox (arsenic trioxide) in the treatment of myelodysplastic syndromes. Leukemia. 2003;17:1499-1507.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献